Drug-tolerant insurgents

Paul Workman and Jon Travers
Additional contact information
Paul Workman: Paul Workman and Jon Travers are in the Cancer Research UK Centre for Cancer Therapeutics, the Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, UK. paul.workman@icr.ac.uk
Jon Travers: Paul Workman and Jon Travers are in the Cancer Research UK Centre for Cancer Therapeutics, the Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, UK. paul.workman@icr.ac.uk

Nature, 2010, vol. 464, issue 7290, 844-845

Abstract: Some cancer cells that become tolerant to a drug remain resistant even after its withdrawal, yet these cells eventually become sensitive to the drug again. The underlying molecular mechanism is unusual.

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/464844a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:464:y:2010:i:7290:d:10.1038_464844a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/464844a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().